
The study developed a CAF-related risk model for skin cutaneous melanoma (SKCM) using TCGA and GEO datasets. Low-risk patients showed better survival and higher immunotherapy sensitivity. CAFs were classified into three subgroups, with antigen-presenting CAFs (apCAFs) linked to poor prognosis and immune suppression. Findings suggest that CAF targeting may enhance therapeutic responses, making this model a promising prognostic and treatment tool.
Like
Save
Share